On-Treatment Change in d -Dimer Is Associated With Differential Outcomes Among Therapeutic Dose Heparin-Treated Noncritically Ill Patients Hospitalized for COVID-19
Rattachement africain : us, ca, au. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
This study is reporting on a clinical randomized control trial: Yes Clinical trial reports should comply with the Consolidated Standards of Reporting Trials ( CONSORT) including its additional extensions as appropriate.This should include a flow diagram presenting the screening, enrollment, intervention allocation, follow-up, and data analysis with number of subjects for each.Please refer specifically to the CONSORT Checklist of items to include when reporting a randomized clinical trial and provide the completed checklist at the time of submission.Please confirm and provide the following details at this time: Clinical Trial RegistrationClinical trials should be registered in an appropriate online trial registry at or before the onset of participant enrollment.In the box below, please provide the name of the trial registry, the registry URL, and the trial registration number.If your study is a clinical trial but not registered, please provide an explanation below.https://classic.clinicaltrials.gov/ct2/show/NCT04505774 Sex and Race/Ethnicity Specific ResultsSex and race/ethnicity specific results of the trial's primary outcomes are reported regardless of whether there are significant differences by sex or race. Yes Diverse Representation -ParticipantsWere steps taken to ensure diverse representation among trial participants, and if so, are these efforts outlined in the methods?If No, a lack of diversity should be explained and listed as a limitation. Yes Diverse Representation -Steering CommitteeWere steps taken to ensure diverse representation among the trial steering committee, and if so, are these efforts outlined in the Methods including demographic information?If No, a lack of diversity should be explained and listed as a limitation.Yes
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé, mais le titre doit être comparé manuellement.
- Titre Crossref
- On-Treatment Change in <scp>d</scp> -Dimer Is Associated With Differential Outcomes Among Therapeutic Dose Heparin-Treated Noncritically Ill Patients Hospitalized for COVID-19
- Date Crossref
- 01/01/2025
- Éditeur
- Ovid Technologies (Wolters Kluwer Health)
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Les institutions déclarées
Une affiliation ne permet pas de déduire la nationalité d’un auteur.